Inflammatory-induced hibernation in the fetus: Priming of fetal sheep metabolism correlates with developmental brain injury

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Keller, Matthias ^a   Enot, David P ^a   Hodson, Mark P ^b   Igwe, Emeka I ^c   Deigner, Hans Peter ^d   Dean, Justin ^e   Bolouri, Hayde ^e   Hagberg, Henrik ^f   Mallard, Carina ^e  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BIOCRATES LIFE SCIENCES AG   (Austria)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; N(G),N(G) DIMETHYLARGININE; OXYGEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN INJURY; BRAIN SIZE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; FETUS; FETUS DEVELOPMENT; GRAY MATTER; HIBERNATION; HISTOPATHOLOGY; INFLAMMATION; METABOLOMICS; NONHUMAN; OXYGEN TENSION; PRENATAL PERIOD; QUANTITATIVE ANALYSIS; SHEEP; UPREGULATION; WHITE MATTER; ACUTE PHASE RESPONSE; ANIMAL; ARTERY; BLOOD; BLOOD GAS ANALYSIS; DRUG EFFECT; METABOLISM; METABOLOME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; VITAL SIGN;

ANIMALIA; OVIS ARIES;

ACUTE-PHASE REACTION; ANIMALS; ARTERIES; BLOOD GAS ANALYSIS; BRAIN INJURIES; FETUS; HIBERNATION; INFLAMMATION; LIPOPOLYSACCHARIDES; METABOLOME; SHEEP; VITAL SIGNS;

EID: 84855290973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029503     Document Type: Article

References (71)

1. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, et al. (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88: 31-38.
2. Marlow N, Wolke D, Bracewell MA, Samara M, Group EPICS (2005) Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 352: 9-19.
3. Mestan K, Yu Y, Matoba N, Cerda S, Demmin B, et al. (2010) Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics 125: e891-e898.
4. Malaeb S, Dammann O, (2009) Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol 24: 1119-1126.
5. Jobe AH, (2011) The new bronchopulmonary dysplasia. Curr Opin Pediatr 23: 167-172.
6. Wang X, Hellgren G, Löfqvist C, Li W, Hellström A, et al. (2009) White matter damage after chronic subclinical inflammation in newborn mice. J Child Neurol 24: 1171-1178.
7. Dean JM, van de Looij Y, Sizonenko SV, Lodygensky GA, Lazeyras F, et al. (2011) Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol pp. n/a-n/a.
8. Brealey D, Brand M, Hargreaves I, Heales S, Land J, et al. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360: 219-223.
9. Illig T, Gieger C, Zhai G, Römisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
10. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, et al. (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411.
11. Wikoff WR, Pendyala G, Siuzdak G, Fox HS, (2008) Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the cns of siv-infected macaques. J Clin Invest 118: 2661-2669.
12. Enot DP, Haas B, Weinberger KM, (2011) Bioinformatics for mass spectrometry-based metabolomics. Methods Mol Biol 719: 351-375.
13. Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, et al. (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5: e13953.
14. McIntosh GH, Baghurst KI, Potter BJ, Hetzel BS, (1979) Foetal brain development in the sheep. Neuropathol Appl Neurobiol 5: 103-114.
15. Barlow RM, (1969) The foetal sheep: morphogenesis of the nervous system and histochemical aspects of myelination. J Comp Neurol 135: 249-262.
16. Kohmura Y, Kirikae T, Kirikae F, Nakano M, Sato I, (2000) Lipopolysaccharide (lps)-induced intrauterine fetal death (iufd) in mice is principally due to maternal cause but not fetal sensitivity to lps. Microbiol Immunol 44: 897-904.
17. Garnier Y, Frigiola A, Volti GL, Florio P, Frulio R, et al. (2009) Increased maternal/fetal blood s100 b levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod Sci 16: 758-766.
18. Duncan JR, Cock ML, Scheerlinck JPY, Westcott KT, McLean C, et al. (2002) White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 52: 941-949.
19. Duncan JR, Cock ML, Rees S, Harding R, (2003) The effects of repeated endotoxin exposure on placental structure in sheep. Placenta 24: 786-789.
20. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, et al. (2004) Toll-like receptor-2 and-4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 191: 1346-1355.
21. Beijar ECE, Mallard C, Powell TL, (2006) Expression and subcellular localization of tlr-4 in term and first trimester human placenta. Placenta 27: 322-326.
22. den Akker CHV, Goudoever JBV, (2010) Recent advances in our understanding of protein and amino acid metabolism in the human fetus. Curr Opin Clin Nutr Metab Care 13: 75-80.
23. Hay WW, Regnault TRH, (2007) Fetal requirements and placental transfer of nitrogenous compounds. In: Polin RA, Fox ASWW, editors. Fetal and neonatal physiology Philedelphia Saunders pp. 509-526.
24. Bell AW, Kennaugh JM, Battaglia FC, Makowski EL, Meschia G, (1986) Metabolic and circulatory studies of fetal lamb at midgestation. Am J Physiol 250: E538-E544.
25. Carver TD, Hay WW, (1995) Uteroplacental carbon substrate metabolism and o2 consumption after long-term hypoglycemia in pregnant sheep. Am J Physiol 269: E299-E308.
26. Ligam PDN, Manuelpillai U, Wallace E, Walker DW, (2010) Nfκb-dependent increase of kynurenine pathway activity in human placenta: inhibition by sulfasalazine. Placenta 31: 997-1002.
27. Kreymann G, Grosser S, Buggisch P, Gottschall C, Matthaei S, et al. (1993) Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 21: 1012-1019.
28. Vary TC, (1996) Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock 6: 89-94.
29. Singer M, (2007) Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 35: S441-S448.
30. Claus RA, Bunck AC, Bockmeyer CL, Brunkhorst FM, Lösche W, et al. (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J 19: 1719-1721.
31. Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, et al. (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in tnfr1-associated periodic syndrome (traps). J Exp Med 208: 519-533.
32. González A, Varo N, Alegre E, Díaz A, Melero I, (2008) Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. Adv Clin Chem 45: 155-197.
33. Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, et al. (2008) Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem 105: 1346-1357.
34. Stone TW, Perkins MN, (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in cns. Eur J Pharmacol 72: 411-412.
35. Stone TW, (2001) Kynurenines in the cns: from endogenous obscurity to therapeutic importance. Prog Neurobiol 64: 185-218.
36. Schwarcz R, Whetsell WO, Mangano RM, (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219: 316-318.
37. Giles GI, Collins CA, Stone TW, Jacob C, (2003) Electrochemical and in vitro evaluation of the redox-properties of kynurenine species. Biochem Biophys Res Commun 300: 719-724.
38. Björkhem I, Diczfalusy U, (2002) Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22: 734-742.
39. Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A, (1997) Importance of a novel oxidative mechanism for elimination of brain cholesterol. turnover of cholesterol and 24(s)- hydroxycholesterol in rat brain as measured with 18o2 techniques in vivo and in vitro. J Biol Chem 272: 30178-30184.
40. Schönknecht P, Lütjohann D, Pantel J, Bardenheuer H, Hartmann T, et al. (2002) Cerebrospinal fluid 24 s-hydroxycholesterol is increased in patients with alzheimer's disease compared to healthy controls. Neurosci Lett 324: 83-85.
41. Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, et al. (2004) Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med 42: 186-191.
42. Bretillon L, Sidén A, Wahlund LO, Lütjohann D, Minthon L, et al. (2000) Plasma levels of 24shydroxycholesterol in patients with neurological diseases. Neurosci Lett 293: 87-90.
43. Teunissen CE, Dijkstra CD, Polman CH, Hoogervorst ELJ, von Bergmann K, et al. (2003) Decreased levels of the brain specific 24 s-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci Lett 347: 159-162.
44. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, et al. (2000) Plasma 24shydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for alzheimer's disease. Neuroreport 11: 1959-1962.
45. Trousson A, Bernard S, Petit PX, Liere P, Pianos A, et al. (2009) 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase a2 type iia via lxr beta and pxr. J Neurochem 109: 945-958.
46. Alexandrov P, Cui JG, Zhao Y, Lukiw WJ, (2005) 24 s-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Neuroreport 16: 909-913.
47. Schroepfer GJ, (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80: 361-554.
48. Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, et al. (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128.
49. Nishiyama Y, Ueda M, Katsura KI, Otsuka T, Abe A, et al. (2010) Asymmetric dimethylarginine (adma) as a possible risk marker for ischemic stroke. J Neurol Sci 290: 12-15.
50. Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, et al. (2003) Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18: 2542-2550.
51. Blackwell S, O'Reilly DSJ, Reid D, Talwar D, (2010) Plasma dimethylarginines during the acute inflammatory response. Eur J Clin Invest.
52. Fink MP, (2002) Bench-to-bedside review: Cytopathic hypoxia. Crit Care 6: 491-499.
53. Zhang Z, Lowry SF, Guarente L, Haimovich B, (2010) Roles of sirt1 in the acute and restorative phases following induction of inflammation. J Biol Chem 285: 41391-41401.
54. Levy RJ, (2007) Mitochondrial dysfunction, bioenergetic impairment, and metabolic downregulation in sepsis. Shock 28: 24-28.
55. Perkins MN, Stone TW, (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247: 184-187.
56. Stone TW, Darlington LG, (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1: 609-620.
57. Andiné P, Lehmann A, Ellrén K, Wennberg E, Kjellmer I, et al. (1988) The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett 90: 208-212.
58. Urban M, Enot DP, Dallmann G, Körner L, Forcher V, et al. (2010) Complexity and pitfalls of mass spectrometry-based targeted metabolomics in brain research. Anal Biochem 406: 124-131.
59. Solberg R, Enot D, Deigner HP, Koal T, Scholl-Bürgi S, et al. (2010) Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 5: e9606.
60. Food and Drug Administration (2001) Fda guidance for industry: Bioanalytical method validation. Technical report, Food and Drug Administration, Center for Drug Evaluation and Research.
61. Zuur A, Ieno E, Walker N, Saveliev A, Smith G, (2009) Mixed Effects Models and Extensions in Ecology with R. Springer, 1st edition.
62. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
63. Tabor CW, Tabor H, (1984) Polyamines. Annu Rev Biochem 53: 749-790.
64. Ha HC, Woster PM, Yager JD, Casero RA, (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci U S A 94: 11557-11562.
65. Jensen JR, Lynch G, Baudry M, (1987) Polyamines stimulate mitochondrial calcium transport in rat brain. J Neurochem 48: 765-772.
66. Koenig H, Goldstone AD, Lu CY, Trout JJ, (1990) Brain polyamines are controlled by n-methyld- aspartate receptors during ischemia and recirculation. Stroke 21: III98-II102.
67. Paschen W, (1992) Polyamine metabolism in different pathological states of the brain. Mol Chem Neuropathol 16: 241-271.
68. Rao AM, Hatcher JF, Doǧan A, Dempsey RJ, (2000) Elevated n1-acetylspermidine levels in gerbil and rat brains after cns injury. J Neurochem 74: 1106-1111.
69. Babu GN, Sailor KA, Beck J, Sun D, Dempsey RJ, (2003) Ornithine decarboxylase activity in in vivo and in vitro models of cerebral ischemia. Neurochem Res 28: 1851-1857.
70. Babu GN, Sailor KA, Sun D, Dempsey RJ, (2001) Spermidine/spermine n1-acetyl transferase activity in rat brain following transient focal cerebral ischemia and reperfusion. Neurosci Lett 300: 17-20.
71. Clarkson AN, Liu H, Pearson L, Kapoor M, Harrison JC, et al. (2004) Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB J 18: 1114-1116.